$PRLB

WEHRWEIN SVEN sold $155K of PRLB

WEHRWEIN SVEN sold 2,000 shares of Proto Labs Inc (PRLB) at an average of $77.28 ($76.91–$78.38, $0.15M total) across 2 trades on 2026-06-02.

Original reporting
SEC EDGAR · WEHRWEIN SVEN
Published Jun 4, 2026, 8:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PRLB
Bearish
medium confidence
Mentioned
$PRLB
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRLBBearishLow
01

Why it matters

The director's sale reduces his ownership, which may be interpreted by the market as a slight bearish cue, though the retained stake mitigates the signal.

02

Market read

Insider sales are watched by traders for potential sentiment shifts; this modest sale may cause slight short‑term pressure on PRLB.

03

What to watch

No 10b5‑1 plan and the director retains a sizable stake, indicating continued confidence.

Relevance 4/10Novelty 5/10Timing: post‑market today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$PRLBBearishMedium confidence
Context

Director Sven Wehrwein sold 2,000 shares of Proto Labs for $154.5K, reducing his stake to 32,505 shares.

Expected impact

likely modest downward pressure as the market prices in the insider sell.

Evidence & confidence

Form 4 filings are primary disclosures; a $155K sale by a director is material for a micro‑cap, but the amount is modest.

Market effects

Minimal impact on the broader manufacturing services sector.

Limited to U.S. small‑cap investors.

None

Counterpoint

The sale could be a routine liquidity move, not a negative signal.

Key entities

  • Proto Labs Inc

    US‑listed manufacturer of rapid‑prototyping services (ticker PRLB).

  • Sven Wehrwein

    Director of Proto Labs who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARWMed

Arrow Electronics, Methode Electronics, Proto Labs, and SolarEdge Shares Skyrocket, What You Need To Know

Arrow Electronics (ARW), Methode Electronics (MEI), Proto Labs (PRLB), and SolarEdge (SEDG) shares rose after weaker-than-expected U.S. jobs data lowered Treasury yields. The Bureau of Labor Statistics reported nonfarm payrolls increased by 29,000 in September, below expectations. Lower yields ease borrowing costs for industrial companies, but slower hiring may signal economic cooling. SolarEdge's stock is up 5.4% year-to-date but remains 57.9% below its 52-week high.

$PRLBMed

Is Proto Labs (PRLB) Fully Valued As A New COO Reshapes Operations?

Proto Labs (PRLB) appointed Sam Ramahi as Chief Operations Officer, focusing on operational leadership and global supply chain management. The stock has seen a 12-month total shareholder return of 60.09% and a year-to-date return of 55.29%, closing at $79.74. Analysts debate whether the current price reflects its shift, with a fair value estimate of $95.50, citing strong cash generation and growth potential. However, risks include customer concentration and weakness in Europe, and the stock trad

$PRLBLow

Protolabs Names Sam Ramahi COO to Lead Global Manufacturing Operations

Protolabs (PRLB) appointed Sam Ramahi as COO to lead global operations. Ramahi, with 25 years of experience, will oversee supply chain, quality, and continuous improvement. He previously led operations at SIG Group and Jacuzzi. The move supports Protolabs' strategy to expand from prototyping to production, aiming to improve performance and create value for shareholders.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.